Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
liver disease
5
×
national blog main
allergan
nash
acelity
acquisition
apax partners
botox
breast implant
breast reconstruction
buyout
chase pharmaceutical corp.
employment
exome
fired
job cut
jobs
joe woody
kci
kinetic concepts
lay off
layoff
leveraged buyout
life science
lifecell
medical device
medical devices
merger
national top stories
negative-pressure wound healing
neurodegenerative disorder
new hire
new york blog main
non-alcoholic steatohepatitis
plastic surgery
private equity
reconstructive surgery
restructuring
rhythm pharmaceuticals
What
acelity
antonio
known
san
company
deal
liver
new
products
wound
ace
acquired
aiming
ambys
approved
bandages
big
billion
biotech
business
consortium
control
cuts
data
deadly
debuted
decades
disease
diseases
drug
ending
equity
eyes
fatty
firms
formed
future
healing
horizon
initial
Language
Current search:
" liver disease "
×
@xconomy.com
5 years ago
Acelity Sells to 3M in Deal Valued at $6.7 Billion, Ending IPO Plan
@xconomy.com
5 years ago
San Antonio Wound-Care Company Eyes (Another) Initial Public Offering
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
San Antonio Life Science Business Acelity Cuts 260 Jobs in Texas, NC
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?